StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
5
Publishing Date
2022 - 03 - 14
1
2022 - 02 - 10
1
2021 - 10 - 15
1
2021 - 04 - 13
1
2021 - 04 - 08
1
Sector
Health technology
5
Professional, scientific, and technical services
1
Tags
Acquisition
9
Alliances
7
America
30
Antibody
10
Application
12
Approval
22
Asia
8
Biosimilar
21
Biotech-bay
28
Biotech-beach
13
Cancer
91
Cell
7
Clinical-trials-phase-iii
9
Collaboration
10
Companies
11
Conference
35
Deadline
21
Disease
26
Drug
54
Earnings
9
Eb613
11
Europe
15
Events
15
Expected
10
Fda
23
Financial
25
Financial results
13
Gene therapy
7
Global
83
Growing
15
Growth
102
Health
10
Leukemia
10
Liver
7
Lumakras
15
Lung
7
Lung cancer
16
Market
220
N/a
569
Osteoporosis
11
People
26
Pharma
12
Pharmaceuticals
8
Phase 2
15
Phase 3
7
Positive
14
Potential
9
Psoriasis
12
Reach
8
Report
58
Research
45
Results
53
Risk
9
Set
8
Technology
12
Therapeutics
69
Therapy
42
Treatment
46
Trial
13
Update
8
Entities
Amgen inc.
5
Becton, dickinson and company
1
Beigene, ltd.
1
Bristol-myers squibb company
1
Eli lilly and company
1
Glaxosmithkline plc
1
Insulet corporation
1
Ionis pharmaceuticals, inc.
1
Johnson & johnson
1
Lonza group ag
1
Medtronic plc
2
Mirati therapeutics, inc.
1
Moderna, inc.
1
Novartis ag
1
Revolution medicines, inc.
1
Sanofi
2
West pharmaceutical services, inc.
1
Symbols
AAPL
13
ABB
28
ABCL
11
ABT
38
ACN
10
ADBE
11
ADMP
17
ADTX
13
APDN
29
ARVL
57
BDX
25
BNTX
61
CSCO
12
CVAC
13
CVS
13
DGX
11
DHR
13
DOW
16
DVAX
41
FNCTF
16
GE
11
GENE
12
GILD
14
GOOG
17
GOOGL
17
GSK
34
HGEN
18
HON
30
HPQ
12
INO
15
JNJ
298
LH
11
LLY
62
MDT
17
MESO
16
MMM
12
MRK
21
MRNA
98
NRXP
38
NVAX
67
NVS
17
OCGN
18
OSUR
12
PFE
58
PHG
15
QDEL
18
QGEN
16
RDHL
20
REGN
17
SAP
22
SNY
128
SNYNF
43
SRNE
35
TAK
11
TAYD
22
TMO
36
TNXP
20
TOMDF
26
VIR
18
VXRT
20
Exchanges
Nasdaq
5
Nyse
3
Crawled Date
2022 - 03 - 14
1
2022 - 02 - 10
1
2021 - 10 - 15
1
2021 - 04 - 13
1
2021 - 04 - 08
1
Crawled Time
12:00
2
16:00
1
22:00
2
Source
www.biospace.com
1
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Covid
symbols :
Amgn
save search
Global Lumakras Drug Market By Therapy Type, Disease Indication, and Region (Including COVID-19 Impact Analysis): A Report by Absolute Markets Insights
Published:
2022-03-14
(Crawled : 16:00)
- prnewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
172.74%
|
O:
1.01%
H:
0.71%
C:
0.0%
RVMD
S
|
$34.95
-2.46%
-2.52%
1.2M
|
Health Technology
|
73.21%
|
O:
0.15%
H:
0.72%
C:
-9.31%
MRNA
S
|
$101.44
-0.55%
-0.55%
2.6M
|
Health Technology
|
-26.62%
|
O:
1.45%
H:
18.94%
C:
7.04%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
-27.18%
|
O:
-0.78%
H:
3.11%
C:
-5.4%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
18.19%
|
O:
1.34%
H:
0.0%
C:
0.0%
covid-19
lumakras
drug
covid
disease
report
therapy
mRNA Manufacturing and Synthesis Services Market worth $22.6 Billion by 2031- Growing Beyond COVID-19 Application
Published:
2022-02-10
(Crawled : 12:00)
- prnewswire.com
LZAGF
|
$563.5
-19.1%
6
|
Health Technology
|
-21.2%
|
O:
-1.72%
H:
0.46%
C:
-0.51%
LZAGY
|
$55.65
0.02%
32K
|
Professional, Scientific, and T...
|
-18.56%
|
O:
-1.31%
H:
2.63%
C:
0.75%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.25%
|
O:
-0.92%
H:
0.0%
C:
0.0%
IONS
|
$40.64
-0.42%
-0.42%
850K
|
Health Technology
|
23.09%
|
O:
0.7%
H:
3.82%
C:
0.78%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
11.66%
|
O:
-2.42%
H:
0.49%
C:
-2.63%
covid-19
application
covid
services
growing
Global Wearable Injector Market: Global Forecast to 2026 With Cumulative Impact of COVID-19
Published:
2021-10-15
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
|
Email alert
Add to watchlist
WST
|
$372.04
-1.4%
0.0%
440K
|
Health Technology
|
Email alert
Add to watchlist
BDX
|
$234.12
0.42%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
PODD
|
$166.255
0.93%
0.92%
840K
|
Health Technology
|
Email alert
Add to watchlist
covid
covid-19
Outlook on the End Stage Renal Disease Global Market to 2025 - Competitive Analysis and Impact of COVID-19
Published:
2021-04-13
(Crawled : 22:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
8.95%
|
O:
-0.17%
H:
0.5%
C:
0.34%
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
|
-35.71%
|
O:
-0.02%
H:
1.02%
C:
0.24%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
10.29%
|
O:
0.67%
H:
0.11%
C:
-0.41%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-23.04%
|
O:
0.27%
H:
0.33%
C:
0.09%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-7.7%
|
O:
0.56%
H:
0.18%
C:
-0.4%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
7.59%
|
O:
0.01%
H:
0.61%
C:
-0.14%
covid
disease
renal
BeiGene Provides Update on Phase 2 Clinical Trial of Zanubrutinib in Patients with COVID-19-Related Pulmonary Distress
Published:
2021-04-08
(Crawled : 12:00)
- biospace.com/
BGNE
|
$129.51
-1.86%
-1.89%
300K
|
Health Technology
|
-59.73%
|
O:
1.06%
H:
0.92%
C:
-3.19%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
8.39%
|
O:
0.39%
H:
0.15%
C:
-0.89%
covid
phase 2
trial
brukinsa
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.